» Articles » PMID: 18376401

Direct Proteasome-independent Cross-presentation of Viral Antigen by Plasmacytoid Dendritic Cells on Major Histocompatibility Complex Class I

Overview
Journal Nat Immunol
Date 2008 Apr 1
PMID 18376401
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

Although plasmacytoid dendritic cells (pDCs) respond to virus replication in a nonspecific way by producing large amounts of type I interferon, a rapid, direct function for pDCs in activating antiviral lymphocytes is less apparent. Here we show that pDCs were able to rapidly initiate antigen-specific antiviral CD8+ T cell responses. After being exposed to virus, pDCs efficiently and rapidly internalized exogenous viral antigens and then presented those antigens on major histocompatibility complex (MHC) class I to CD8+ T cells. Processing of exogenous antigen occurred in endocytic organelles and did not require transit of antigen to the cytosol. Intracellular stores of MHC class I partially localized together with the transferrin receptor and internalized transferrin in endosomes, which suggested that such recycling endosomes are sites for loading peptide onto MHC class I or for peptide transit. Our data demonstrate that pDCs use 'ready-made' stores of MHC class I to rapidly present exogenous antigen to CD8+ T cells.

Citing Articles

Cross-priming in cancer immunology and immunotherapy.

Luri-Rey C, Teijeira A, Wculek S, de Andrea C, Herrero C, Lopez-Janeiro A Nat Rev Cancer. 2025; .

PMID: 39881005 DOI: 10.1038/s41568-024-00785-5.


Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.

Chen J, Chen J, Wang L J Zhejiang Univ Sci B. 2022; 23(10):812-822.

PMID: 36226536 PMC: 9561406. DOI: 10.1631/jzus.B2200174.


Vaccine adjuvants to engage the cross-presentation pathway.

Lee W, Suresh M Front Immunol. 2022; 13:940047.

PMID: 35979365 PMC: 9376467. DOI: 10.3389/fimmu.2022.940047.


DCs at the center of help: Origins and evolution of the three-cell-type hypothesis.

Wu R, Murphy K J Exp Med. 2022; 219(7).

PMID: 35543702 PMC: 9098650. DOI: 10.1084/jem.20211519.


Human dendritic cell subsets: An updated view of their ontogeny and functional specialization.

Segura E Eur J Immunol. 2022; 52(11):1759-1767.

PMID: 35187651 PMC: 9790408. DOI: 10.1002/eji.202149632.


References
1.
Kuchtey J, Chefalo P, Gray R, Ramachandra L, Harding C . Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. J Immunol. 2005; 175(4):2244-51. DOI: 10.4049/jimmunol.175.4.2244. View

2.
Stern L, Potolicchio I, Santambrogio L . MHC class II compartment subtypes: structure and function. Curr Opin Immunol. 2005; 18(1):64-9. DOI: 10.1016/j.coi.2005.11.005. View

3.
Moseman E, Liang X, Dawson A, Panoskaltsis-Mortari A, Krieg A, Liu Y . Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol. 2004; 173(7):4433-42. DOI: 10.4049/jimmunol.173.7.4433. View

4.
Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, Reis e Sousa C . The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med. 2000; 191(6):927-36. PMC: 2193115. DOI: 10.1084/jem.191.6.927. View

5.
Gilliet M, Liu Y . Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med. 2002; 195(6):695-704. PMC: 2193733. DOI: 10.1084/jem.20011603. View